ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Autoimmune Disease Therapeutics Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-4V2417
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Autoimmune Disease Therapeutics Market Insights and Forecast to 2028
BUY CHAPTERS

Global Autoimmune Disease Therapeutics Market Research Report 2025

Code: QYRE-Auto-4V2417
Report
September 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol–Myers Squibb
Amgen Inc
Bayer
F.Hoffmann-La Roche
Eli Lilly and Company
Johnson & Johnson Services

Autoimmune Disease Therapeutics Market Size

The global market for Autoimmune Disease Therapeutics was valued at US$ 105750 million in the year 2024 and is projected to reach a revised size of US$ 124560 million by 2031, growing at a CAGR of 2.4% during the forecast period.

Autoimmune Disease Therapeutics Market

Autoimmune Disease Therapeutics Market

North American market for Autoimmune Disease Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Autoimmune Disease Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Autoimmune Disease Therapeutics in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Autoimmune Disease Therapeutics include Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen, Bayer, F. Hoffmann-La Roche, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Therapeutics.
The Autoimmune Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmune Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Autoimmune Disease Therapeutics Market Report

Report Metric Details
Report Name Autoimmune Disease Therapeutics Market
Accounted market size in year US$ 105750 million
Forecasted market size in 2031 US$ 124560 million
CAGR 2.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Immunosuppressants
  • Anti-Inflammatory Drugs
  • Corticosteroids
  • Nonsteroidal Anti-inflammatory Drugs
  • Biologics
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Independent Pharmacies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen, Bayer, F. Hoffmann-La Roche, Eli Lilly and Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Autoimmune Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Autoimmune Disease Therapeutics Market growing?

Ans: The Autoimmune Disease Therapeutics Market witnessing a CAGR of 2.4% during the forecast period 2025-2031.

What is the Autoimmune Disease Therapeutics Market size in 2031?

Ans: The Autoimmune Disease Therapeutics Market size in 2031 will be US$ 124560 million.

Who are the main players in the Autoimmune Disease Therapeutics Market report?

Ans: The main players in the Autoimmune Disease Therapeutics Market are Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen, Bayer, F. Hoffmann-La Roche, Eli Lilly and Company

What are the Application segmentation covered in the Autoimmune Disease Therapeutics Market report?

Ans: The Applications covered in the Autoimmune Disease Therapeutics Market report are Hospitals, Clinics, Independent Pharmacies, Others

What are the Type segmentation covered in the Autoimmune Disease Therapeutics Market report?

Ans: The Types covered in the Autoimmune Disease Therapeutics Market report are Immunosuppressants, Anti-Inflammatory Drugs, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs, Biologics, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunosuppressants
1.2.3 Anti-Inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Nonsteroidal Anti-inflammatory Drugs
1.2.6 Biologics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Autoimmune Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Independent Pharmacies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Autoimmune Disease Therapeutics Growth Trends by Region
2.2.1 Global Autoimmune Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autoimmune Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Autoimmune Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Autoimmune Disease Therapeutics Market Dynamics
2.3.1 Autoimmune Disease Therapeutics Industry Trends
2.3.2 Autoimmune Disease Therapeutics Market Drivers
2.3.3 Autoimmune Disease Therapeutics Market Challenges
2.3.4 Autoimmune Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Therapeutics Players by Revenue
3.1.1 Global Top Autoimmune Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Autoimmune Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Autoimmune Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autoimmune Disease Therapeutics Revenue
3.4 Global Autoimmune Disease Therapeutics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Autoimmune Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Autoimmune Disease Therapeutics, Product and Application
3.7 Global Key Players of Autoimmune Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Therapeutics Breakdown Data by Type
4.1 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Autoimmune Disease Therapeutics Breakdown Data by Application
5.1 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autoimmune Disease Therapeutics Market Size (2020-2031)
6.2 North America Autoimmune Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autoimmune Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Autoimmune Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Disease Therapeutics Market Size (2020-2031)
7.2 Europe Autoimmune Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autoimmune Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Autoimmune Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Autoimmune Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Autoimmune Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autoimmune Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Autoimmune Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Autoimmune Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Autoimmune Disease Therapeutics Introduction
11.1.4 Pfizer Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Autoimmune Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Details
11.3.2 Johnson & Johnson Services Business Overview
11.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Introduction
11.3.4 Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.3.5 Johnson & Johnson Services Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Autoimmune Disease Therapeutics Introduction
11.4.4 Merck Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Autoimmune Disease Therapeutics Introduction
11.5.4 Sanofi Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.5.5 Sanofi Recent Development
11.6 Abott
11.6.1 Abott Company Details
11.6.2 Abott Business Overview
11.6.3 Abott Autoimmune Disease Therapeutics Introduction
11.6.4 Abott Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.6.5 Abott Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Autoimmune Disease Therapeutics Introduction
11.8.4 Amgen Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.8.5 Amgen Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Autoimmune Disease Therapeutics Introduction
11.9.4 Bayer Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Introduction
11.11.4 Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2020-2025)
11.11.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol–Myers Squibb
Amgen Inc
Bayer
F.Hoffmann-La Roche
Eli Lilly and Company
Johnson & Johnson Services
List of Tables
 Table 1. Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immunosuppressants
 Table 3. Key Players of Anti-Inflammatory Drugs
 Table 4. Key Players of Corticosteroids
 Table 5. Key Players of Nonsteroidal Anti-inflammatory Drugs
 Table 6. Key Players of Biologics
 Table 7. Key Players of Others
 Table 8. Global Autoimmune Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Autoimmune Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Autoimmune Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Autoimmune Disease Therapeutics Market Share by Region (2020-2025)
 Table 12. Global Autoimmune Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Autoimmune Disease Therapeutics Market Share by Region (2026-2031)
 Table 14. Autoimmune Disease Therapeutics Market Trends
 Table 15. Autoimmune Disease Therapeutics Market Drivers
 Table 16. Autoimmune Disease Therapeutics Market Challenges
 Table 17. Autoimmune Disease Therapeutics Market Restraints
 Table 18. Global Autoimmune Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Autoimmune Disease Therapeutics Market Share by Players (2020-2025)
 Table 20. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2024)
 Table 21. Ranking of Global Top Autoimmune Disease Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Autoimmune Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Autoimmune Disease Therapeutics, Headquarters and Area Served
 Table 24. Global Key Players of Autoimmune Disease Therapeutics, Product and Application
 Table 25. Global Key Players of Autoimmune Disease Therapeutics, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Autoimmune Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2020-2025)
 Table 29. Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2026-2031)
 Table 31. Global Autoimmune Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2020-2025)
 Table 33. Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2026-2031)
 Table 35. North America Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Autoimmune Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Autoimmune Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Autoimmune Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Autoimmune Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Autoimmune Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Autoimmune Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Autoimmune Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Pfizer Company Details
 Table 51. Pfizer Business Overview
 Table 52. Pfizer Autoimmune Disease Therapeutics Product
 Table 53. Pfizer Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 54. Pfizer Recent Development
 Table 55. Novartis Company Details
 Table 56. Novartis Business Overview
 Table 57. Novartis Autoimmune Disease Therapeutics Product
 Table 58. Novartis Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 59. Novartis Recent Development
 Table 60. Johnson & Johnson Services Company Details
 Table 61. Johnson & Johnson Services Business Overview
 Table 62. Johnson & Johnson Services Autoimmune Disease Therapeutics Product
 Table 63. Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 64. Johnson & Johnson Services Recent Development
 Table 65. Merck Company Details
 Table 66. Merck Business Overview
 Table 67. Merck Autoimmune Disease Therapeutics Product
 Table 68. Merck Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 69. Merck Recent Development
 Table 70. Sanofi Company Details
 Table 71. Sanofi Business Overview
 Table 72. Sanofi Autoimmune Disease Therapeutics Product
 Table 73. Sanofi Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 74. Sanofi Recent Development
 Table 75. Abott Company Details
 Table 76. Abott Business Overview
 Table 77. Abott Autoimmune Disease Therapeutics Product
 Table 78. Abott Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 79. Abott Recent Development
 Table 80. Bristol-Myers Squibb Company Details
 Table 81. Bristol-Myers Squibb Business Overview
 Table 82. Bristol-Myers Squibb Autoimmune Disease Therapeutics Product
 Table 83. Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 84. Bristol-Myers Squibb Recent Development
 Table 85. Amgen Company Details
 Table 86. Amgen Business Overview
 Table 87. Amgen Autoimmune Disease Therapeutics Product
 Table 88. Amgen Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 89. Amgen Recent Development
 Table 90. Bayer Company Details
 Table 91. Bayer Business Overview
 Table 92. Bayer Autoimmune Disease Therapeutics Product
 Table 93. Bayer Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 94. Bayer Recent Development
 Table 95. F. Hoffmann-La Roche Company Details
 Table 96. F. Hoffmann-La Roche Business Overview
 Table 97. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Product
 Table 98. F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 99. F. Hoffmann-La Roche Recent Development
 Table 100. Eli Lilly and Company Company Details
 Table 101. Eli Lilly and Company Business Overview
 Table 102. Eli Lilly and Company Autoimmune Disease Therapeutics Product
 Table 103. Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2020-2025) & (US$ Million)
 Table 104. Eli Lilly and Company Recent Development
 Table 105. Research Programs/Design for This Report
 Table 106. Key Data Information from Secondary Sources
 Table 107. Key Data Information from Primary Sources
 Table 108. Authors List of This Report


List of Figures
 Figure 1. Autoimmune Disease Therapeutics Picture
 Figure 2. Global Autoimmune Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Autoimmune Disease Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Immunosuppressants Features
 Figure 5. Anti-Inflammatory Drugs Features
 Figure 6. Corticosteroids Features
 Figure 7. Nonsteroidal Anti-inflammatory Drugs Features
 Figure 8. Biologics Features
 Figure 9. Others Features
 Figure 10. Global Autoimmune Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Autoimmune Disease Therapeutics Market Share by Application: 2024 VS 2031
 Figure 12. Hospitals Case Studies
 Figure 13. Clinics Case Studies
 Figure 14. Independent Pharmacies Case Studies
 Figure 15. Others Case Studies
 Figure 16. Autoimmune Disease Therapeutics Report Years Considered
 Figure 17. Global Autoimmune Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Autoimmune Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Autoimmune Disease Therapeutics Market Share by Region: 2024 VS 2031
 Figure 20. Global Autoimmune Disease Therapeutics Market Share by Players in 2024
 Figure 21. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Autoimmune Disease Therapeutics Revenue in 2024
 Figure 23. North America Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Autoimmune Disease Therapeutics Market Share by Country (2020-2031)
 Figure 25. United States Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Autoimmune Disease Therapeutics Market Share by Country (2020-2031)
 Figure 29. Germany Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Region (2020-2031)
 Figure 37. China Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Autoimmune Disease Therapeutics Market Share by Country (2020-2031)
 Figure 45. Mexico Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Country (2020-2031)
 Figure 49. Turkey Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Autoimmune Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Pfizer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 53. Novartis Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 54. Johnson & Johnson Services Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 55. Merck Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 56. Sanofi Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 57. Abott Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 59. Amgen Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 60. Bayer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 62. Eli Lilly and Company Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Autoimmune Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Disease Testing Market Research Report 2024
Global Autoimmune Diseases Treatment Market Research Report 2024
Systemic Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Localized Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autoimmune Disorder Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Autoimmune Disorder Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune and Inflammatory Immunomodulators Market Research Report 2024
Global Canavan Disease Therapeutics Market Research Report 2024
Global Health Product for Immune Market Research Report 2024
Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Drugs Market Insights Forecast to 2030
Global Joint Disease Therapeutics Market Research Report 2024
Mitochondrial Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatoid Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autologous Biologics Market Research Report 2025
Global Apheresis Market Research Report 2024
Inflammatory Bowel Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions